- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03409523
An Observational Pilot Study to Develop a Behavioral Economics Electronic Health Record Module to Guide the Care of Older Adults With Diabetes
This study will develop a new electronic health record module to improve guideline-compliant care of older adults with diabetes. The module will incorporate effective behavioral economics (BE) principles to improve the degree to which care of older adults is compliant with Choosing Wisely guidelines; this generally involves less aggressive targets for HbA1c, and reductions of medications other than metformin.
The implementation of the module will ultimately be triggered by medication prescribing in EPIC. The BE principles include suggesting alternatives to medications, requiring justification, setting of appropriate default order sets, and incorporation of anchoring and checklists to guide behavior. The study will involve provider workflow analysis based on observation, module user testing, and live usability testing with direct observation and semi-structure interviews.
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
New York
-
New York, New York, United States, 10016
- New York University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Providers in NYU outpatient primary care, geriatrics, or endocrine clinics at NYU who care for older adults with diabetes
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Compliance with Choosing Wisely guidelines measured by number of reductions of medications
Time Frame: 60 Months
|
The implementation of the module will ultimately be triggered by medication prescribing in EPIC.
|
60 Months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Usability measured by module user testing with direct observation and semi structured interviews
Time Frame: 60 Months
|
60 Months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Andrea Troxel, MD, NYU Langone Health
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 17-01308
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabete Mellitus
-
SeraxisNot yet recruitingDiabete Mellitus | Diabete Type 1
-
Medanta, The Medicity, IndiaCompletedDiabete Mellitus | Diabete Type 2 | Hyperglycaemia (Diabetic)India
-
Rio Grande do Sul State Health Department - SES/RSAgnes Nogueira Gossenheimer; Ana Paula Rigo; Roberto Eduardo SchneidersNot yet recruitingTelemedicine | Diabete Mellitus | Diabete Type 2 | TelehealthBrazil
-
Assiut UniversityNot yet recruiting
-
King Abdulaziz UniversityEnrolling by invitation
-
Hospices Civils de LyonCompletedDiabete Type 2 | Diabete Type 1France
-
Dong-A ST Co., Ltd.Not yet recruiting
-
Bahria UniversityCompleted
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI); University of Abuja Teaching...Not yet recruiting
-
Dong-A ST Co., Ltd.Not yet recruiting